| ATC code B: Blood and blood forming organs |
|---|
|
| Other ATC codes |
ATC code B02 Antihemorrhagics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup B02 is part of the anatomical group B Blood and blood forming organs.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB02.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
B02A Antifibrinolytics[edit]
B02AA Amino acids[edit]
- B02AA01 Aminocaproic acid
- B02AA02 Tranexamic acid
- B02AA03 Aminomethylbenzoic acid
B02AB Proteinase inhibitors[edit]
- B02AB01 Aprotinin
- B02AB02 Alfa1 antitrypsin
- B02AB04 Camostat
- B02AB05 Ulinastatin
B02B Vitamin K and other hemostatics[edit]
B02BA Vitamin K[edit]
- B02BA01 Phytomenadione
- B02BA02 Menadione
B02BB Fibrinogen[edit]
- B02BB01 Human fibrinogen
B02BC Local hemostatics[edit]
- B02BC01 Absorbable gelatin sponge
- B02BC02 Oxidized cellulose
- B02BC03 Tetragalacturonic acid hydroxymethylester
- B02BC05 Adrenalone
- B02BC06 Thrombin
- B02BC07 Collagen
- B02BC08 Calcium alginate
- B02BC09 Epinephrine
- B02BC30 Combinations
B02BD Blood coagulation factors[edit]
- B02BD01 Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
- B02BD02 Coagulation factor VIII
- B02BD03 Factor VIII inhibitor bypassing activity
- B02BD04 Coagulation factor IX
- B02BD05 Coagulation factor VII
- B02BD06 von Willebrand factor and coagulation factor VIII in combination
- B02BD07 Coagulation factor XIII
- B02BD08 Coagulation factor VIIa
- B02BD10 von Willebrand factor
- B02BD11 Catridecacog
- B02BD13 Coagulation factor X
- B02BD14 Susoctocog alfa
- B02BD15 Valoctocogene roxaparvovec
- B02BD16 Etranacogene dezaparvovec
- B02BD30 Thrombin
B02BX Other systemic hemostatics[edit]
- B02BX01 Etamsylate
- B02BX02 Carbazochrome
- B02BX03 Batroxobin
- B02BX04 Romiplostim
- B02BX05 Eltrombopag
- B02BX06 Emicizumab
- B02BX07 Lusutrombopag
- B02BX08 Avatrombopag
- B02BX09 Fostamatinib
- B02BX10 Concizumab
References[edit]
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code B02". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QB02". WHO Collaborating Centre for Drug Statistics Methodology.